153 related articles for article (PubMed ID: 37000620)
1. Protocol for performing pooled CRISPR-Cas9 loss-of-function screens.
Mathiowetz AJ; Roberts MA; Morgens DW; Olzmann JA; Li Z
STAR Protoc; 2023 Mar; 4(2):102201. PubMed ID: 37000620
[TBL] [Abstract][Full Text] [Related]
2. Protocol of CRISPR-Cas9 knockout screens for identifying ferroptosis regulators.
Yang X; Duan S; Li Z; Wang Z; Kon N; Zhang Z; Gu W
STAR Protoc; 2023 Dec; 4(4):102762. PubMed ID: 38048220
[TBL] [Abstract][Full Text] [Related]
3. Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library.
Olivieri M; Durocher D
STAR Protoc; 2021 Mar; 2(1):100321. PubMed ID: 33598657
[TBL] [Abstract][Full Text] [Related]
4. Protocol for genome-wide CRISPR knockout screens of bacterial cytotoxins in HeLa cells.
Yang Q; Zhou Y; He L; Zhang Y; Tao L
STAR Protoc; 2022 Sep; 3(3):101595. PubMed ID: 35928004
[TBL] [Abstract][Full Text] [Related]
5. Pooled CRISPR-activation screening coupled with single-cell RNA-seq in mouse embryonic stem cells.
Alda-Catalinas C; Eckersley-Maslin MA; Reik W
STAR Protoc; 2021 Jun; 2(2):100426. PubMed ID: 33899013
[TBL] [Abstract][Full Text] [Related]
6. Generation of a pooled shRNA library for functional genomics screens.
Papadopoulos D; Ade CP; Eilers M
STAR Protoc; 2022 Mar; 3(1):101183. PubMed ID: 35243374
[TBL] [Abstract][Full Text] [Related]
7. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
8. Protocol to expand and CRISPR-Cas9 genomic edit murine MAIT cells for subsequent in vivo studies.
du Halgouet A; Darbois A; Alphonse A; Yvorra T; Colombeau L; Rodriguez R; Lantz O; Salou M
STAR Protoc; 2023 Sep; 4(3):102419. PubMed ID: 37432855
[TBL] [Abstract][Full Text] [Related]
9. Protocol for biallelic tagging of an endogenous gene using CRISPR-Cas9 in human cells.
Kong N; Chan YW
STAR Protoc; 2023 May; 4(2):102286. PubMed ID: 37252842
[TBL] [Abstract][Full Text] [Related]
10. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
Farooq U; Notani D
STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
[TBL] [Abstract][Full Text] [Related]
11. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells.
Angelopoulou A; Papaspyropoulos A; Papantonis A; Gorgoulis VG
STAR Protoc; 2022 Jun; 3(2):101257. PubMed ID: 35330963
[TBL] [Abstract][Full Text] [Related]
13. Scalable CRISPR-Cas9 chemical genetic screens in non-transformed human cells.
Lin K; Chang YC; Marron Fernandez de Velasco E; Wickman K; Myers CL; Bielinsky AK
STAR Protoc; 2022 Dec; 3(4):101675. PubMed ID: 36107744
[TBL] [Abstract][Full Text] [Related]
14. caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR/Cas9 screens.
Winter J; Breinig M; Heigwer F; Brügemann D; Leible S; Pelz O; Zhan T; Boutros M
Bioinformatics; 2016 Feb; 32(4):632-4. PubMed ID: 26508755
[TBL] [Abstract][Full Text] [Related]
15. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
[TBL] [Abstract][Full Text] [Related]
16. High-throughput genetic screens using CRISPR-Cas9 system.
Kweon J; Kim Y
Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
[TBL] [Abstract][Full Text] [Related]
17. Protocol for genome-scale CRISPR screening in engineered lineage reporter hPSCs to study cell fate determination.
Zhou Z; Ma L; Zhang X
STAR Protoc; 2021 Jun; 2(2):100548. PubMed ID: 34095862
[No Abstract] [Full Text] [Related]
18. Pooled CRISPR-Based Genetic Screens in Mammalian Cells.
Chan K; Tong AHY; Brown KR; Mero P; Moffat J
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31545321
[TBL] [Abstract][Full Text] [Related]
19. Protocol for genome-scale in vivo CRISPR screening to study protection of beta cells under autoimmunity in a type 1 diabetes mouse model.
Li J; Lee YC; Iessi IL; Wu C; Yi P; Cai EP
STAR Protoc; 2023 Mar; 4(2):102155. PubMed ID: 36917606
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Directed Gene Editing for the Generation of Loss-of-Function Mutants in High-Throughput Zebrafish F
Shankaran SS; Dahlem TJ; Bisgrove BW; Yost HJ; Tristani-Firouzi M
Curr Protoc Mol Biol; 2017 Jul; 119():31.9.1-31.9.22. PubMed ID: 28678442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
